SEC Form 4 · accession 0001104659-15-051687
MARINUS PHARMACEUTICALS INC · MRNS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Timothy M Mayleben
Director
Period of report
Jul 16, 2015
Accepted (ET)
Jul 17, 2015 · 4:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001267813
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 16, 2015 | M | 15,515 | $1.04 | A | 15,515 | D | |
| Common Stock | Jul 16, 2015 | M | 27,035 | $1.04 | A | 42,550 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock option (right to buy)F1 | $1.04 | Jul 16, 2015 | M | 15,515 | D | — | Jun 9, 2019 | Common Stock | 15,515 | 0 | D |
| Stock option (right to buy)F2 | $1.04 | Jul 16, 2015 | M | 27,035 | D | — | Mar 20, 2022 | Common Stock | 27,035 | 0 | D |
Explanation of responses
- F125% vested on 6/9/09; remaining shares vested in equal installments at the end of each of the 36 months after 6/9/09.
- F2100% vested on 3/20/13.